An overview of the once‐weekly GLP‐1 receptor agonists from the pharmacist’s perspective

Lignende værker

• Glycaemic and non‐glycaemic efficacy of once‐weekly GLP‐1 receptor agonists in people with type 2 diabetes
  af: Patel, Dhiren
  Udgivet: (2020)
• Safety and tolerability of once‐weekly GLP‐1 receptor agonists in type 2 diabetes
  af: Trujillo, Jennifer
  Udgivet: (2020)
• Glycemic monitoring with once-weekly Glucagon-like peptide 1 receptor agonist (GLP1RA) use
  af: Kalra, Sanjay, et al.
  Udgivet: (2015)
• Dulaglutide (Trulicity): The Third Once-Weekly GLP-1 Agonist
  af: Smith, Lillian L., et al.
  Udgivet: (2016)
• Cardiovascular safety outcomes of once‐weekly GLP‐1 receptor agonists in people with type 2 diabetes
  af: Goldman, Jennifer D.
  Udgivet: (2020)